Inventor · disambiguated record
Vincent Segers
Also filed as: SEGERS VINCENT · SEGERS VINCENT FRANS MARIA
6 granted patents·5 pending applications·21 citations·filing 2007–2022
79Inventor score
Files withBRIGHAM & WOMENS HOSPITAL3BRIGHAM & WOMENS HOSPITAL INC3UNIV ANTWERPEN3MESOBLAST INT SARL1SEGERS VINCENT FRANS MARIA1
Top patents by PatentIndex Score
11 records- 0187US7696309B2Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damageBRIGHAM & WOMENS HOSPITAL·Filed 2007·Granted Apr 13, 2010·8 cites·16 claims
- 0283US7999067B2Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damageBRIGHAM & WOMENS HOSPITAL·Filed 2010·Granted Aug 16, 2011·5 cites·15 claims
- 0377US9631005B2Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damageBRIGHAM & WOMENS HOSPITAL INC·Filed 2013·Granted Apr 25, 2017·2 cites·6 claims
- 0475US9308277B2Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damageSEGERS VINCENT FRANS MARIA·Filed 2011·Granted Apr 12, 2016·6 cites·33 claims
- 0572US2022009984A9Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damageBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Application pending·0 cites
- 0663US10774124B2Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damageBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Sep 15, 2020·0 cites·11 claims
- 0757US2024002351A1Quinazolin-4-one and thieno[2,3-d]pyrimidin-4-one inhibitors of erbb4 (her4) for use in the treatment of cancerUNIV ANTWERPEN·Filed 2022·Application pending·0 cites
- 0856US2011269685A1Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damageBRIGHAM & WOMENS HOSPITAL·Filed 2011·Application pending·0 cites
- 0943US10456451B2Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damageMESOBLAST INT SARL·Filed 2016·Granted Oct 29, 2019·0 cites·21 claims
- 1033US2017333529A1Neuregulin in the treatment of fibrotic disordersUNIV ANTWERPEN·Filed 2016·Application pending·0 cites
- 1131US2017035848A1Treatment of nephropathyUNIV ANTWERPEN·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →